Cite
HARVARD Citation
Burstein, H. et al. (2021). Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update. Journal of clinical oncology. 39 (35), pp. 3959-3977. [Online].